Single-Cell RNA Sequencing Revealed CD14 Monocytes Increased in Patients With Takayasu's Arteritis Requiring Surgical Management.

Takayasu Arteritis (TA) is a highly specific vascular inflammation and poses threat to patients' health. Although some patients have accepted medical treatment, their culprit lesions require surgical management (TARSM). This study aimed at dissecting the transcriptomes of peripheral blood mononuclear cells (PBMCs) in these patients and to explore potential clinical markers for TA development and progression. Peripheral blood were collected from four TA patients requiring surgical management and four age-sex matched healthy donors. Single cell RNA sequencing (scRNA-seq) was adopted to explore the transcriptomic diversity and function of their PBMCs. ELISA, qPCR, and FACS were conducted to validate the results of the analysis. A total of 29918 qualified cells were included for downstream analysis. Nine major cell types were confirmed, including CD14 monocytes, CD8 T cells, NK cells, CD4 T cells, B cells, CD16 monocytes, megakaryocytes, dendritic cells and plasmacytoid dendritic cells. CD14 monocytes (50.0 vs. 39.3%, < 0.05) increased in TA patients, as validated by FACS results. TXNIP, AREG, THBS1, and CD163 increased in TA patients. ILs like IL-6, IL-6STP1, IL-6ST, IL-15, and IL-15RA increased in TA group. Transcriptome heterogeneities of PBMCs in TA patients requiring surgical management were revealed in the present study. In the patients with TA, CD14 monocytes and gene expressions involved in oxidative stress were increased, indicating a new treatment and research direction in this field.